Screener
Royalty Pharma RPRX Payments for Employee Equity Performance Awards
Payments for Employee Equity Performance Awards at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept rprx:PaymentsForEmployeeEquityPerformanceAwards.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's payments for employee equity performance awards?
- Royalty Pharma (RPRX) reported payments for employee equity performance awards of $4.55M in Q2 2026.
- How has Royalty Pharma's payments for employee equity performance awards changed year-over-year?
- Royalty Pharma's payments for employee equity performance awards increased by 2529.5% year-over-year, from $173K to $4.55M.
- What does payments for employee equity performance awards mean?
- Represents cash payments made to employees related to equity-based performance awards. This reflects the cost of incentivizing management and staff through performance-linked compensation. It is a component of total personnel-related cash outflows.
Ask your AI about Royalty Pharma's payments for employee equity performance awards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude